Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-062646

President & CEO sold 16,650 shares at $1.75 ($29,138)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-17 Sale : show line 1 in the form −16,650 $1.75 $29,138 863,239 D
Open-market sales · 16,650 sh · avg $1.75 · $29,138
Loading xslF345X05/ownership.xml…